Skip to main content
OpenTrials

Clinical trial condition

Duchenne Muscular Dystrophy

Explore clinical trials studying Duchenne Muscular Dystrophy. Study availability and eligibility vary by location and protocol.

216 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Duchenne Muscular Dystrophy trial results

Active, not recruiting

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

NCT05881408

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • University of California at Davis Medical Center Sacramento, California, United States
  • Rady Children's Hospital-San Diego San Diego, California, United States
View all 46 locations
View Trial Details
Active, not recruiting

A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy

NCT06713135

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • UZ Gent (Universitair Ziekenhuis Gent) Ghent, Belgium
  • UZ Leuven (Universitair Ziekenhuis Leuven) Leuven, Belgium
  • University Hospital Brno Brno, Czechia
  • Fakultni Nemocnice Motol Prague, Czechia
View all 18 locations
View Trial Details
Active, not recruiting

A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)

NCT05540860

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 14 locations
View Trial Details
Active, not recruiting

Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy

NCT06100887

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States
View Trial Details
Active, not recruiting

Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)

NCT04687020

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • UC Davis Sacramento, California, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Children's Hospital of Richmond at VCU Richmond, Virginia, United States
View Trial Details
Completed

A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）

NCT04587908

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Fukuoka, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Osaka, Japan
View Trial Details

Related conditions